Understanding Barriers to Establishing Public JYNNEOS Mpox Vaccination Clinics in New Hampshire: Mpox vaccine clinic NH.

Autor:	Kang H; Section of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA., Mahatanan R; Section of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA., Lee D; Section of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA., Locke S; New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire, USA., Talbot EA; Section of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA.; New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire, USA., Chan BP; Section of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA.; New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire, USA.
Jazyk:	angličtina
Zdroj:	Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2024 Sep 18; Vol. 18, pp. e121. Date of Electronic Publication: 2024 Sep 18.
DOI:	10.1017/dmp.2024.99
Abstrakt:	Objective: 2022 - 2023 mpox outbreak necessitated rapid distribution of JYNNEOS vaccines from US Strategic National Stockpile to state and local public health agencies. New Hampshire's centralized public health structure required partnering with healthcare facilities to reach at-risk persons. Among the 67 organizations contacted to partner with, only 7 established public JYNNEOS vaccine clinics. The study objective was to identify barriers and resources needed for emergency public vaccination. Methods: In March 2023, mixed-method surveys were developed and sent to 20 non-participating organizations and 7 participating organizations ("vaccine-partners"). Results: 35% (7/20) of non-participating organizations and 100% (7/7) vaccine-partners responded. Non-participating organizations (n = 5) identified lack of staffing (100%) and insufficient provider time or clinical resources (80%) as the most common barriers. Staffing needs reported by non-participating organizations included: administrative (100%); medical doctor or advanced practice practitioner (67%); and registered nurse, medical assistant, or licensed nursing assistant (67%). Vaccine partners reported similar staffing requirements. Estimated additional monthly funding needs were $3,750 for non-participating organizations and $1,680 for vaccine-partners. Conclusions: A minority of NH healthcare facilities established public JYNNEOS vaccination clinics. The primary barrier was insufficient staffing; additional resources and funding needs were modest. Success of the next emergency vaccination campaign depends on sustained advocacy, resources, and partnership.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu